MétaCan
Menu
Back to cohort
Record W2140658698 · doi:10.1186/s13058-015-0567-2

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

2015· article· en· W2140658698 on OpenAlexafffund
Sophie Blein, Claire Bardel, Vincent Danjean, Lesley McGuffog, Sue Healey, Daniel Barrowdale, Andrew Lee, Joe Dennis, Karoline Kuchenbaecker, Penny Soucy, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Susan L. Neuhausen, Yuan Chun Ding, Anne‐Marie Gerdes, Bent Ejlertsen, Finn C. Nielsen, Thomas van Overeem Hansen, Ana Osório, Javier Benı́tez, Raquel Andrés Conejero, E. Segota, Jeffrey N. Weitzel, Margo Thelander, Paolo Peterlongo, Paolo Radice, Valeria Pensotti, Riccardo Dolcetti, Bernardo Bonanni, Bernard Peissel, Daniela Zaffaroni, Giulietta Scuvera, Siranoush Manoukian, Liliana Varesco, Gabriele Lorenzo Capone, Laura Papi, Laura Ottini, Drakoulis Yannoukakos, Irene Konstantopoulou, Judy Garber, U. Hamann, Alan Donaldson, Angela Brady, Carole Brewer, Claire Foo, D. Gareth Evans, Debra Frost, Diana Eccles, Fiona Douglas, Jackie Cook, Julian Adlard, Julian Barwell, Lisa Walker, Louise Izatt, Lucy Side, Marc Tischkowitz, Mark T. Rogers, Mary Porteous, Patrick J. Morrison, Radka Platte, Rosalind A. Eeles, R Davidson, Shirley Hodgson, T Cole, Andrew K. Godwin, Claudine Isaacs, Kathleen Claes, Kim De Leeneer, Alfons Meindl, Andrea Gehrig, Barbara Wappenschmidt, Christian Sutter, Christoph Engel, Dieter Niederacher, Doris Steinemann, Hansjoerg Plendl, Karin Kast, Kerstin Rhiem, Nina Ditsch, Norbert Arnold, Raymonda Varon-Mateeva, Rita K. Schmutzler, Sabine Preisler‐Adams, Nadja Bogdanova Markov, Shan Wang‐Gohrke, Antoine de Pauw, Cédrick Lefol, Christine Lasset, Dominique Leroux, Étienne Rouleau, Francesca Damiola, Hélène Dreyfus, Laure Barjhoux, Lisa Golmard, Nancy Uhrhammer, Valérie Bonadona, Valérie Sornin, Yves‐Jean Bignon, Jonathan Carter, Linda Van Le, Marion Piedmonte, Paul DiSilvestro, Miguel de la Hoya, Trinidad Caldés, Heli Nevanlinna, Kristiina Aittomäki, Agnes Jager, Ans MW van den Ouweland, Carolien M. Kets, Cora M. Aalfs, Flora E. van Leeuwen, Frans B.L. Hogervorst, Hanne Meijers‐Heijboer, Jan C. Oosterwijk, Kees EP van Roozendaal, Matti A. Rookus, Peter Devilee, Rob B. van der Luijt, Edith Olah, Orland Dı́ez, Àlex Teulé, Conxi Lázaro, Ignacio Blanco, Jesús Del Valle, Anna Jakubowska, Grzegorz Sukiennicki, Jacek Gronwald, Jan Lubiński, Katarzyna Durda, Katarzyna Jaworska-Bieniek, Bjarni A. Agnarsson, Christine Maugard, Alberto Amadori, Marco Montagna, Manuel R. Teixeira, Amanda B Spurdle, William D. Foulkes, Curtis Olswold, Noralane M. Lindor, V. Shane Pankratz, Csilla I. Szabo, Anne Lincoln, Marina Corines, Mark E. Robson, Joseph Vijai, Andreas Berger, Anneliese Fink-Retter, Christian F. Singer, Christine Rappaport, Daphne Geschwantler Kaulich, Georg Pfeiler, Muy-Kheng Tea, Mark H. Greene, Gad Rennert, Evgeny N. Imyanitov, Anna Marie Mulligan, Gord Glendon, Irene L. Andrulis, Sandrine Tchatchou, Amanda E. Toland, Inge Søkilde Pedersen, Mads Thomassen, Torben A. Kruse, Uffe Birk Jensen, Maria A. Caligo, Eitan Friedman, Jamal Zidan, Yael Laitman, Annika Lindblom, Beatrice Melin, Brita Arver, Niklas Loman, Richard Rosenquist, Olufunmilayo I. Olopade, Robert L. Nussbaum, Susan J. Ramus, Katherine L. Nathanson, Susan M. Domchek, Timothy R. Rebbeck, Banu Arun, Gillian Mitchell, Beth Y. Karlan, Jenny Lester, Sandra Oršulić, Dominique Stoppa-Lyonnet, Gilles Thomas, Jacques Simard, Fergus J. Couch, Kenneth Offit, Douglas F. Easton, Georgia Chenevix‐Trench, Antonis C Antoniou, Sylvie Mazoyer, Catherine M. Phelan, Olga M. Sinilnikova, David G. Cox

Bibliographic record

VenueBreast Cancer Research · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMitochondrial Function and Pathology
Canadian institutionsSt. Michael's HospitalCancer Care OntarioUniversity of TorontoMcGill UniversityUniversité LavalLunenfeld-Tanenbaum Research InstituteMount Sinai HospitalCentre hospitalier de l'Université LavalCanada Research ChairsCentre hospitalier universitaire de Québec
FundersJonsson Comprehensive Cancer CenterMedical Research CouncilNational Institutes of HealthCentre Léon BérardNational Cancer InstituteLiga Portuguesa Contra o CancroMinistero dello Sviluppo EconomicoRadboud Universitair Medisch CentrumDeutsche KrebshilfeUniversitair Medisch Centrum GroningenLeids Universitair Medisch CentrumHospices Civils de LyonMinisterio de Ciencia e InnovaciónEuropean Regional Development FundCentre National de la Recherche ScientifiqueNational Health and Medical Research CouncilJewish General HospitalState Education Development Agency Republic of LatviaLietuvos Mokslo TarybaUniversity of California, Los AngelesUniversità degli Studi di FirenzeKWF KankerbestrijdingUniversitair Ziekenhuis GentNederlandse Organisatie voor Wetenschappelijk OnderzoekMinistero della SaluteGeneralitat de CatalunyaErasmus Medisch CentrumPomorski Uniwersytet Medyczny W SzczecinieVrije Universiteit AmsterdamNIH Office of the DirectorInstitut Claudius RegaudUniversiteit LeidenCancer AustraliaNational Breast Cancer FoundationMinisterstvo Zdravotnictví Ceské RepublikyCentre Hospitalier Universitaire de NantesEuropean CommissionNational Institute for Health and Care ResearchCanadian Breast Cancer Research AllianceGénome QuébecDavid F. and Margaret T. Grohne Family FoundationBreast Cancer Research FoundationMcGill UniversityUniverzita Karlova v PrazeUnicancerClalit Health ServicesDeutsches KrebsforschungszentrumU.S. Department of DefenseCancer Research UKAssociazione Italiana per la Ricerca sul CancroBeckman Research Institute, City of HopeCancer Center, University of KansasCancerfondenRadboud UniversiteitMinistère du Développement Économique, de l’Innovation et de l’ExportationFundación Mutua MadrileñaIsrael Cancer AssociationInstitut Català de la SalutInstitut Gustave-RoussyUniversity of PennsylvaniaSusan G. KomenHungarian Scientific Research FundCedars-Sinai Medical CenterFundación Ramón ArecesHelsingin ja Uudenmaan SairaanhoitopiiriLandspítali HáskólasjúkrahúsUniversity of KansasUniversity of California, San FranciscoMasarykova UniverzitaUniversiteit GentMayo ClinicCreighton UniversityIstituto Oncologico VenetoRoyal Marsden NHS Foundation TrustEuropean Social FundUniversity of ChicagoMemorial Sloan-Kettering Cancer CenterCanadian Institutes of Health ResearchGeneral Secretariat for Research and TechnologyDr. Ralph and Marian Falk Medical Research TrustKansas Bioscience AuthorityIstituto Toscano TumoriCancer Association of South AfricaInstituto de Salud Carlos IIIOhio State UniversityInstitut BergoniéAmerican Cancer Society
KeywordsBreast cancerSurgical oncologyHaplogroupMitochondrial DNAHuman mitochondrial DNA haplogroupGeneticsPhylogenetic treeMutationMedicineBiologyBioinformaticsOncologyInternal medicineCancerGeneHaplotypeGenotype

Abstract

fetched live from OpenAlex

INTRODUCTION: Individuals carrying pathogenic mutations in the BRCA1 and BRCA2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double-strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals with different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. In the present study, we tested the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers. METHODS: We genotyped 22,214 (11,421 affected, 10,793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched in affected or unaffected individuals. RESULTS: We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers compared with the rest of clade T (hazard ratio (HR) = 0.55; 95% confidence interval (CI), 0.34 to 0.88; P = 0.01). Compared with the most frequent haplogroup in the general population (that is, H and T clades), the T1a1 haplogroup has a HR of 0.62 (95% CI, 0.40 to 0.95; P = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk. CONCLUSIONS: This study illustrates how original approaches such as the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.455
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.340
Teacher spread0.300 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations35
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicMitochondrial Function and PathologyFrench-language works237,207